121 related articles for article (PubMed ID: 18982737)
1. Hyperleptinemia--non-haemodynamic risk factor for the left ventricular hypertrophy development in hypertensive overweight females.
Selthofer-Relatić K; Radić R; Vizjak V; Vcev A; Kosović P; Bosnjak I; Selthofer R
Coll Antropol; 2008 Sep; 32(3):681-5. PubMed ID: 18982737
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
Kartal O; Inal V; Baysan O; Sağlam K
Anadolu Kardiyol Derg; 2008 Oct; 8(5):342-6. PubMed ID: 18849224
[TBL] [Abstract][Full Text] [Related]
3. Low adiponectin serum level--reduced protective effect on the left ventricular wall thickness.
Selthofer-Relatić K; Radić R; Vcev A; Steiner R; Vizjak V; Sram M; Tripolski M; Kosović P; Bosnjak I; Selthofer R
Coll Antropol; 2011 Sep; 35(3):787-91. PubMed ID: 22053557
[TBL] [Abstract][Full Text] [Related]
4. [Is leptin an independent risk factor for development of left ventricular hypertrophy in obese hypertensive patients?].
Kiliç T
Anadolu Kardiyol Derg; 2008 Oct; 8(5):347-9. PubMed ID: 18849225
[No Abstract] [Full Text] [Related]
5. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between ventricular arrhythmia and blood lipid in hypertensive patients with left ventricular hypertrophy].
Zhao Y; Zhao S; Wang T
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(5):458-60. PubMed ID: 10682560
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence and relevant factors on echocardiographic left ventricular hypertrophy among community-based hypertensive patients in Shanghai].
Zhan S; Liu M; Yao W; Hu Y; Li L; Zhu G; Sun N; Dai L
Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Jun; 23(3):182-5. PubMed ID: 12411085
[TBL] [Abstract][Full Text] [Related]
8. The relationship between blood pressure and left ventricular mass index depends on an excess adiposity.
Norton GR; Majane OH; Libhaber E; Maseko MJ; Makaula S; Libhaber C; Woodiwiss AJ
J Hypertens; 2009 Sep; 27(9):1873-83. PubMed ID: 19512944
[TBL] [Abstract][Full Text] [Related]
9. Reverse correlation between ankle-brachial index and left ventricular hypertrophy in patients on maintenance haemodialysis.
Fu W; Ye C; Mei C; Rong S; Wang W
Nephrology (Carlton); 2006 Feb; 11(1):9-14. PubMed ID: 16509925
[TBL] [Abstract][Full Text] [Related]
10. [Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].
Stojimirović B; Petrović D; Obrenović R
Med Pregl; 2007; 60 Suppl 2():155-9. PubMed ID: 18928184
[TBL] [Abstract][Full Text] [Related]
11. Prolonged recovery time in the left precordial leads reflects increased left ventricular mass in the hypertensive patients.
Hara H; Niwano S; Ikeda N; Izumi T
J Electrocardiol; 2005 Oct; 38(4):406-11. PubMed ID: 16216619
[TBL] [Abstract][Full Text] [Related]
12. [Left ventricular hypertrophy in chronic kidney disease].
Paoletti E; Cannella G
G Ital Nefrol; 2006; 23(6):560-8. PubMed ID: 17173262
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension.
Cuspidi C; Negri F; Giudici V; Valerio C; Meani S; Sala C; Esposito A; Masaidi M; Zanchetti A; Mancia G
J Hypertens; 2009 Apr; 27(4):854-60. PubMed ID: 19516183
[TBL] [Abstract][Full Text] [Related]
14. A common variant of the eNOS gene (E298D) is an independent risk factor for left ventricular hypertrophy in human essential hypertension.
Xin Y; Song X; Xue H; Liu Z; Wang X; Wang H; Sun K; Bai Y; Liu J; Hui R
Clin Sci (Lond); 2009 Jun; 117(2):67-73. PubMed ID: 19132956
[TBL] [Abstract][Full Text] [Related]
15. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
[TBL] [Abstract][Full Text] [Related]
16. [Variants of heart remodeling in essential hypertension: prevalence and determinants].
Konradi AO; Rudomanov OG; Zakharov DV; Vakhrameeva NV; Krutikov AN; Iakovleva OI; Shliakhto EV
Ter Arkh; 2005; 77(9):8-16. PubMed ID: 16281481
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population.
Barrios V; Escobar C; Calderon A; Ribas L; Marti D; Asin E
Blood Press; 2008; 17(2):110-5. PubMed ID: 18568700
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
[TBL] [Abstract][Full Text] [Related]
19. Association of increased arterial stiffness and inflammation with proteinuria and left ventricular hypertrophy in non-diabetic hypertensive patients.
Tsai WC; Lin CC; Huang YY; Chen JY; Chen JH
Blood Press; 2007; 16(4):270-5. PubMed ID: 17852088
[TBL] [Abstract][Full Text] [Related]
20. Hypertensive heart disease.
Manoria PC; Manoria P
J Indian Med Assoc; 1999 Mar; 97(3):81-5. PubMed ID: 10652906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
